Welcome - Home - Register - Login - Help/FAQ - 0 items

Search Enter keywords, a title or a report id number below. In All Categories --------------------- Telecom & Computing Business & Finance Mfg & Construction Pharma & Healthcare Consumer & Retail Gov & Public Sector Energy & Transport Country Reports Company Reports --------------------- Transcripts Advanced      Select a currency for use throughout the site Australia Dollars Canada Dollars Euro Japan Yen Sweden Kroner Switzerland Francs UK Pounds US Dollars Viewing report Order by Fax Printer Friendly PDF Brochure Send to Friend Enquire before Buying Hard Copy Electronic Site License Cell Signal Inhibitors: A New Generation of Prophylactic Agents Datamonitor, Jan 2001   Description     Table of Contents        Enquire before Buying    Send to a Friend   In view of the role of Cox-2 not only in colon cancer, but also in other major tumor indications, Cox-2 inhibitors have the potential to revolutionize cancermanagement, should their reported efficacy against colon polyp recurrencetranslate into a survival advantage. Customers who bought this item also bought Drugs of Tomorrow: Cancer Overview Drugs of Tomorrow: Cancer Overview - The synergistic advance: innovatives compliment traditional chemotherapies Drugs of Tomorrow 2001: Diabetes Drugs of Tomorrow 2000: Prostate Cancer - Hormonals and Beyond Drugs of Tomorrow 2001: Anticoagulants - A pipeline flowing with future blockbusters Drugs of Tomorrow 2001: Cancer Overview Market Dynamics 2001: Hormonals Drugs of Tomorrow 2000: Lung Cancer - New Partners For Old Regimens Niche Cancers 2001: Gastric Cancer Drugs of Tommorrow 2002: Pain Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed Drugs of Tomorrow 2000 Vaccines: A New Era of Disease Targets

		Top of page

All rights reserved. � Copyright 2008 Research and Markets    Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster